Search alternatives:
significant effect » significant impact (Expand Search)
effect decrease » effects decreased (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
significant effect » significant impact (Expand Search)
effect decrease » effects decreased (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
-
81
-
82
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
83
-
84
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
85
-
86
-
87
-
88
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
89
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
90
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
91
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
92
-
93
-
94
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
95
-
96
-
97
-
98
-
99
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…(<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. (<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …”
-
100